TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
HCM

HUTCHMED DRC

Healthcare · Drug Manufacturers - Specialty & Generic

14.20$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

HUTCHMED DRC (HCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 550 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HCM
Line item 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
18 38 50 65 87 111 135 165 22 46 87 178 216 241 214 205 228 356 426 838 630 550
6.1 15 21 28 36 45 55 74 13 22 59 111 156 176 144 160 189 29 311 384 348 337
11 23 29 37 51 66 80 91 9.6 24 28 67 60 65 70 45 40 327 115 454 283 213
1.2 2.0 2.8 5.6 8.8 3.9 6.4 7.3 5.9 4.5 30 47 67 76 116 92 177 299 387 303 213 164
– – – – – – – – 21 21 13 20 22 24 31 39 50 89 92 80 64 67
18 29 35 47 65 71 82 84 2.6 12 47 77 107 119 163 197 238 684 834 436 326 267
-6.4 -5.7 -5.4 -9.7 -14 -4.6 -2.2 4.1 -17 -1.0 -18 -9.8 -47 -53 -93 -153 -199 -357 -719 18 -44 -55
0.4 0.5 0.4 0.3 0.5 0.4 0.4 0.6 1.2 1.5 1.5 1.4 1.6 1.5 1.0 1.0 0.8 0.6 0.7 0.8 2.9 2.9
-7.3 -6.2 -5.8 -10 -15 -5.0 -2.6 4.8 12 10 -4.8 12 19 -20 -67 -101 -111 -155 -361 106 45 523
0.1 0.1 0.0 0.8 1.5 2.1 2.6 3.1 1.1 1.1 1.3 1.6 4.3 3.1 4.0 3.3 4.8 12 -0.3 4.5 7.2 64
-6.7 -6.8 -9.6 -17 -18 -8.7 -6.9 0.7 3.6 5.9 -33 8.0 12 -27 -75 -106 -126 -195 -361 101 38 458
-5.2 -3.4 -2.5 -5.9 -9.6 0.0 2.4 11 14 12 -17 -7.8 -43 -50 -82 -135 -193 -155 -360 27 -31 -41

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?